For full access to this article login to GEN Select now.
For New York to reach the top tier of biotech clusters in the U.S., one focus will need to be on raising more life science venture capital. [© Gary - Fotolia.com]
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.